Since our founding in 2009, the establishment and ongoing expansion of our extramural research program has been a major part of SENS Research Foundation’s commitment to changing the way the world researches and treats age-related disease. We recognize that building and sustaining collaborations throughout a global research community is crucial to the realization of our mission. Toward this end, we fund work at some of the top universities and research institutions in the world. Learn more about each active project and how it relates to SRF’s mission using the links in this section.
This research program has successfully spun-out into a company! Visit the Revel Pharmaceuticals website for more information on their transformative approach to tissue cross-linking and vascular disease.
Principal Investigator: Jean Hébert, PhD
Research Team: Hiroko Nobuta, Joanna Krzyspiak, Alexander Quesada, Marta Gronska-Peski, Jayleecia Smith